Methodology of clinical studies dealing with the treatment of envenomation

被引:22
作者
Chippaux, Jean-Philippe [1 ]
Stock, Roberto P. [2 ]
Massougbodji, Achille [3 ]
机构
[1] Mothers & Children Facing Trop Infect Inst Rech D, IRD UMR 216, Paris, France
[2] Univ Nacl Autonoma Mexico, Inst Biotecnol, Cuernavaca 62210, Morelos, Mexico
[3] Univ Abomey Calavi, Fac Sci Sante Cotonou, Abomey Calavi, Benin
关键词
Envenomations; Treatment; Clinical studies; Clinical trial; Methodology; POLYVALENT IMMUNE FAB; RANDOMIZED COMPARATIVE TRIAL; ACUTE ADVERSE-REACTIONS; OCELLATUS SNAKE BITE; MALAYAN PIT VIPER; DOUBLE-BLIND; CROTALIDAE POLYVALENT; ANTIVENOM THERAPY; SCORPION ENVENOMATION; STATISTICS NOTES;
D O I
10.1016/j.toxicon.2010.02.022
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
A total of 142 clinical studies have been devoted to the treatment of envenomations, of which 115 address snake bites, 20 scorpion stings, and 8 other animals (one addresses both snake and spider envenomation). Antivenom use was studied in 118, of which 82 addressed efficacy, 43 evaluated safety, 23 studied dosage and 8 explored other issues. Besides anecdotal clinical reports, three classes of clinical studies are distinguished: (a) observational clinical studies (55 of the total) which analyze series of cases, (b) comparative clinical studies (36) which compare therapeutic products or treatment regimens without a gold standard for comparison and (c) randomized clinical trials (RCT, 51). The goals, methods and constraints of design of RCT are determined by whether explanatory (analytical) or pragmatic considerations are prioritized. Explanation-oriented RCT rely on strict group comparability before and during treatment, in order to ensure the internal validity of the study. The pragmatically-oriented RCT aims at establishing the superiority of a treatment over another, the goal being to maximize the external validity of the trial (that is, its application in current practice). We found that all clinical studies of treatment of envenomation lean markedly toward the explanatory end and suggest that, given some particularities of envenomation as a medical condition, a more pragmatic approach may be of value, particularly under the conditions prevalent for clinical studies in developing nations. (C) 2010 Elsevier Ltd. All rights reserved.
引用
收藏
页码:1195 / 1212
页数:18
相关论文
共 196 条
[1]   Serotherapy in scorpion envenomation: a randomised controlled trial [J].
Abroug, F ;
ElAtrous, S ;
Nouira, S ;
Haguiga, H ;
Touzi, N ;
Bouchoucha, S .
LANCET, 1999, 354 (9182) :906-909
[2]   High-dose hydrocortisone hemisuccinate in scorpion envenomation [J].
Abroug, F ;
Nouira, S ;
Haguiga, H ;
Elatrous, S ;
Belghith, M ;
Boujdaria, R ;
Touzi, N ;
Bouchoucha, S .
ANNALS OF EMERGENCY MEDICINE, 1997, 30 (01) :23-27
[3]   Pre-clinical and preliminary dose-finding and safety studies to identify candidate antivenoms for treatment of envenoming by saw-scaled or carpet vipers (Echis ocellatus) in northern Nigeria [J].
Abubakar, S. B. ;
Abubakar, I. S. ;
Habib, A. G. ;
Nasidi, A. ;
Durfa, N. ;
Yusuf, P. O. ;
Larnyang, S. ;
Garnvwa, J. ;
Sokomba, E. ;
Salako, L. ;
Laing, G. D. ;
Theakston, R. D. G. ;
Juszczak, E. ;
Alder, N. ;
Warrell, D. A. .
TOXICON, 2010, 55 (04) :719-723
[4]   The efficacy of tow-dose antivenom therapy on morbidity and mortality in snakebite cases [J].
Acikalin, Ayca ;
Gokel, Yuksel ;
Kuvandik, Gueven ;
Duru, Mehmet ;
Koseoglu, Zikret ;
Satar, Salim .
AMERICAN JOURNAL OF EMERGENCY MEDICINE, 2008, 26 (04) :402-407
[5]   Low dose of snake antivenom is as effective as high dose in patients with severe neurotoxic snake envenoming [J].
Agarwal, R ;
Aggarwal, AN ;
Gupta, D ;
Behera, D ;
Jindal, SK .
EMERGENCY MEDICINE JOURNAL, 2005, 22 (06) :397-399
[6]   STATISTICS NOTES - ABSENCE OF EVIDENCE IS NOT EVIDENCE OF ABSENCE [J].
ALTMAN, DG ;
BLAND, JM .
BRITISH MEDICAL JOURNAL, 1995, 311 (7003) :485-485
[7]  
Altman DG, 1996, BRIT MED J, V313, P570
[8]  
Altman DG, 1999, BRIT MED J, V318, P1209
[9]   Poor-quality medical research - What can journals do? [J].
Altman, DG .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2002, 287 (21) :2765-2767
[10]   The revised CONSORT statement for reporting randomized trials: Explanation and elaboration [J].
Altman, DG ;
Schulz, KF ;
Moher, D ;
Egger, M ;
Davidoff, F ;
Elbourne, D ;
Gotzsche, PC ;
Lang, T .
ANNALS OF INTERNAL MEDICINE, 2001, 134 (08) :663-694